Craft

Advanced
  • Home
  •  / Solvotrin Therapeutics
Solvotrin Therapeutics

Solvotrin Therapeutics

Total Funding

$4.4 M

Solvotrin Therapeutics Summary

Company Summary

Overview
Solvotrin Therapeutics is a drug development company focused on chemical modifications of known drugs. Its main product is ActiveIron that is based on the iron-whey protein complex.
Type
Private
Status
Active
Founded
2009
HQ
IE | view all locations
Website
http://www.solvotrin.com/
Cybersecurity rating
Sectors

Table of Contents

Key People

  • Pat O'Flynn

    Pat O'Flynn, President/CEO

    • Mark Ledwidge

      Mark Ledwidge, Vice President Development and Strategy

      • John Gilmer

        John Gilmer, Vice President Research & Development

        • George Walsh

          George Walsh, Chief Financial Officer

          LocationsView all

          1 location detected

          • CO HQ

            Ireland

            R623, Inchera, Co. Cork

          Competitors and Similar Companies

          Compare competitors

          Footer menu

          Product

          Solutions

          Resources

          Company

          © Craft.co 2025
          Share price data provided by IEX